RIGL

RIGL

USD

Rigel Pharmaceuticals Inc. Common Stock

$28.380-1.710 (-5.683%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$30.090

Hoch

$30.795

Tief

$28.080

Volumen

0.31M

Unternehmensfundamentaldaten

Marktkapitalisierung

509.1M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.71M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $13.91Aktuell $28.380Hoch $43.72

Ähnliche Nachrichten

PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

Mehr anzeigen
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
CNBC

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Mehr anzeigen
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...

Mehr anzeigen
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update